Nidek claims Canadian patent victory sets US precedent
This article was originally published in Clinica
Executive Summary
Nidek claims that the decision announced last week to uphold an earlier patent lawsuit in Canada in its favour against Visx opens the way to victory in similar litigation in the US. For its part, Visx dismisses the decision as a "non-event for both parties", and accuses the Japanese company of making "misleading and inaccurate" comments in its press release.